Ireland· IE-PA-PPA0465/109/002
Cozaar Comp 100 mg/25 mg film-coated tablets
A losartan product containing losartan potassium + hydrochlorothiazide, registered in Ireland by PCO Manufacturing Ltd.. The same ATC class is registered in 19 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Losartan is registered in 19 of 19 countries.
Countries holding a registration under ATC C09CA01 (losartan), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 11 of them publish a price we can compare per daily dose
Losartan · ATC C09CA01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of losartan costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.033 in United States to $0.61 in Switzerland — a ×19 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Losartan · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.61
- IT Italy$0.30
- ES Spain$0.17
- FR France$0.10
- US United States$0.033 (acquisition cost)
The record
At a glance
HPRA (Ireland)- Active substance
- Losartan potassium + Hydrochlorothiazide
- Manufacturer
- PCO Manufacturing Ltd.
- Country
- Ireland (IE)
- ATC code
- C09CA01
- ATC class
- Losartan
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPPA0465/109/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
431 interactions on record for losartan.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Losartan · interactions on record
431 records
- 7 severe
- 139 moderate
- 2 minor
- 198 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
85 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Losartan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLORISTA HKrka, d.d., Novo mesto, Novo mesto
- United StatesHYZAAROrganon LLC
- United KingdomCozaar-Comp 100mg/12.5mg tabletsOrganon Pharma (UK) Ltd
- SpainCOZAAR PLUS 50 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAOrganon Salud S.L.
- FinlandAsolzidMylan AB
- ItalyFORZAARORGANON ITALIA S.R.L.
- FranceFORTZAAR 100 mg/12,5 mg, comprimé pelliculéORGANON FRANCE
- SwitzerlandCo-Losartan Sandoz
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Cosaar, Losarcomp
- Belgium · Co-Losartan, Co-Losartan Teva
- Bulgaria · Ко-Хипертоник, Лозап H
- Cyprus · Losar Plus, Losartan/Hydrochlorothiazide Krka
- Czechia · Lorista H, Losartan/Hydrochlorothiazide Zentiva
- Germany · Fortzaar, Lorzaar Plus
- Denmark · Ancozan Comp, Cozaar Comp.
- Estonia · Lorista H, Lorista H 100/25 Mg
- Spain · Cozaar Plus, Fortzaar
- Finland · Cozaar Comp, Cozaar Comp Forte
- France · Fortzaar, Hyzaar
- United Kingdom (Northern Ireland) · Cozaar Comp, Losartan Potassium / Hydrochlorothiazide Generics (Uk)
- Greece · Co-Rabolan, Faxiven
- Croatia · Fortzaar, Hyzaar
- Hungary · Co-Arbartan, Hyzaar
- Iceland · Cozaar Comp, Cozaar Comp Forte
- Italy · Forzaar, Hizaar
- Lithuania · Lorista H, Lozap H
- Luxembourg · Cozaar Plus, Cozaar Plus Forte
- Latvia · Lorista H
- Malta · Losartan/Hydrochlorothiazide Aurobindo
- Netherlands · Cozaar Plus, Entrizen/Hct
- Norway · Asolzid, Cozaar Comp
- Poland · Hyzaar, Hyzaar Forte
- Portugal · Cotiasar, Cozaar Plus
- Romania · Lorista H, Lorista Hl
- Sweden · Cozaar Comp, Cozaar Comp Forte
- Slovenia · Lorista H, Lorista Hd
- Slovakia · Lorista H, Losartan/Hydrochlorothiazid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c70127df-65c1-4e5d-ae54-34e647841567 GET /v1/drugs/c70127df-65c1-4e5d-ae54-34e647841567?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"C09CA",
"C09CA01"
],
"strength": null,
"pa_number": "PPA0465/109/002",
"substances": [
"Losartan potassium",
"Hydrochlorothiazide"
],
"legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
"market_info": "Unknown",
"authorised_at": "08/02/2008",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0031-027-003"
}See everything about losartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.